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1. Introduction 
Glycogen synthase, the rate-limiting enzyme of 
glycogenesis, has been purified from skeletal muscle 
and studied extensively over the past decade. lnvesti- 
gations on the in vitro phosphorylation have shown 
that glycogen synthase contains multiple phosphoryla- 
tion sites per subunit which can be phosphorylated 
by three classes of protein kinases: CAMP-dependent 
protein kinase; Ca*‘-dependent protein kinases; and 
CAMP-independent protein kinase (reviews [l-3]). 
Analysis of tryptic and CNBr [32P] peptides indicate 
the presence of a trypsin-sensitive phosphorylation 
region near the C-terminus and a trypsin-insensitive 
phosphorylation region near the N-terminus of the 
synthase subunit [ 1,4,5]. 
The phosphorylation state of glycogen synthase in 
vivo has not been thoroughly investigated. Insulin 
treatment of rabbits decreased the phosphate content 
of the muscle synthase from 1.33-0.87 mol Pi/mol 
subunit [6]. Epinephrine injection into rabbit in- 
creased the skeletal muscle synthase phosphate content 
from 2.2-3.1 mol Pi/mol subunit [3]. Here we show 
that the phosphorylation state of glycogen synthase 
in rabbit muscle is increased by epinephrine and by 
the diabetic state. However, the distribution of the 
phosphate between the trypsin-sensitive and trypsin- 
insensitive regions differ in these two conditions. The 
data indicate that the CAMP-dependent protein kinase 
Abbreviations: CAMP, adenosine 3’,5’-monophosphate; 
TS, trypsin-sensitive; TI, trypsin-insensitive; G-6-P, glucose- 
6-phosphate, SDS, sodium dodecyl sulfate; MI, relative 
molecular mass 
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is involved in epinephrine action but probably not in 
insulin action. 
2. Methods 
New Zealand female rabbits (3-4 kg body wt) 
were used. Intravenous injection of epinephrine (66 
pg/kg) was at 30 s prior to injection of a lethal dose 
(70 mg/kg) of nembutal. Control and diabetic rabbits 
were sacrificed by injection of propranolol(10 mg/kg). 
Diabetes was induced by intravenous injection of 2 
doses of alloxan (80 mg/kg each) 2 h apart. Blood 
glucose values of diabetic rabbits were 2350 mg% 
compared to 80-l 20 mg% of control rabbits. The 
diabetic condition was maintained 5-7 days before 
use of the animals. 
Immediately following injection of nembutal the 
rabbits were bled from the jugular vein, skinned, and 
the hindleg muscle excised, ground and homogenized 
in cold 4 mM EDTA, 1 mM EGTA, 50 mM NaF, 10 
mM P-glycerol phosphate, 30 mM 2-mercaptoethanol 
(pH 7.0). The time elapse between nembutal injection 
and completion of homogenization was <5 min. Syn- 
thase was then purified in the cold as in [7] except 
that 50 mM NaF was included in all buffers, and the 
acid precipitation was at pH 5.8 rather than 6.1. The 
amylase digestion of the glycogen pellet was modified 
in that amylase was 0.5 mg/ml, no Mg*’ was present, 
and the digestion time was 30 min. The purified syn- 
thase showed a single major protein band at -90 000 
J4, and a minor band at -45 000 M, when subjected 
to SDS disc-gel electrophoresis [7]. 
Glycogen synthase was assayed as in [7]. Alkali- 
labile phosphate in purified glycogen synthase was 
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determined as in [9]. Phosphate analyses were done 
on synthase before and after trypsinization (0.125 
mg trypsin/ml for 1 C mm, see [lo]) to determine 
trypsin-sensitive and trypsin-insensitive phosphate. 
To verify that the limited trypsinization was working 
as in [4], aliquots of synthase from control, epineph- 
rine-treated, and diabetic rabbits were phosphorylated 
using [-Y-~‘P] ATP. Each sample was analyzed for tryp- 
sin-sensitive and trypsin-insensitive 32P as above. A 
second aliquot of each was hydrolyzed with CNBr 
and the [32P]peptides eparated by SDS disc-gel elec- 
trophoresis in [4]. In all 3 samples the distribution of 
32P as trypsin-sensitive or trypsin-insensitive corre- 
sponded with the distribution of 32P between the 
high and low Mr CNBr [“‘PI peptides. 
3. Results and discussion 
Many types of control experiments were performed 
to ensure that the phosphorylation state of glycogen 
synthase was not altered by killing of the rabbits, 
removal and/or homogenization of the muscle, and 
purification of the enzyme. Details of these controls 
will be published elsewhere and only summarized 
here. Most of these controls relied on the fact that 
measurement of the synthase activity ratio plus the 
K, for G-6-P would indicate any alteration of the 
phosphorylation state of the enzyme [ 1 l-1 41. These 
two kinetic properties of synthase were measured in 
muscle extracts from the standard homogenization; 
muscle frozen in situ at the temperature of liquid 
nitrogen and homogenized at -20°C in 60% glycerol 
[IS]; and extracts from rabbits sacrificed using pro- 
pranolol or nembutal. These kinetic parameters were 
Table 1 
Kinetic parameters of glycogen synthase during purification 
Fraction Activity ratio G-6-P 
(-G-6-P/+G-6-P) K, 0.W 
Frozen muscle extract 0.23 182 
Fresh muscle extract 0.24 170 
pH 5.8 precipitate 0.24 174 
Glycogen pellet 0.21 170 
DEAE-cellulose (peak tube) 0.22 183 
Purified enzyme 0.24 175 
Glycogen synthase was purified from a fresh muscle extract, 
and the synthase activity ratio and G-6-P K, were determined 
at each stage. In addition a sample of muscle was frozen in 
situ, powdered, and homogenized at -20°C [15] before 
determination of the synthase kinetic parameters 
also determined at each stage of the purification pro- 
cedure (table 1). All these control experiments indi- 
cated that the phosphorylation state measured in the 
purified enzyme was a true reflection of the in vivo 
phosphorylation state. 
The synthase activity ratios and Ka for G-6-P 
(table 2) suggested that synthase from control animals 
was already partially phosphorylated since non-phos- 
phorylated synthase has a ratio of -0.8 and a K, of 
5-l 0 PM [ 11. Phosphate analyses showed that syn- 
thase from controls contained -2.4 mol Pi/subunit. 
As expected, epinephrine treatment produced a 
decrease in the synthase activity ratio, increase in G-6-P 
K, value, and the phosphate content was elevated to 
-3.9 mol/mol subunit. These results are in general 
agreement with [3,16]. The somewhat higher phos- 
phate contents and lower activity ratios of the latter 
study may reflect the fact that they used perfused rat 
Table 2 
Glycogen synthase was purified from control, epinephrine-treated, and diabetic rabbits 
Treatment Activity ratio G-6-P Phosphate content (mol/mol subunit) 
(-G-6-P/+G-6-P) K, (&I) 
Total TS TI 
Control (6) 0.24 + 0.03 166 * 39 2.35 + 0.29 0.95 + 0.10 1.40 + 0.12 
Epinephrine (5) 0.07 * 0.02a 768 * 117a 3.85 i: 0.26a 2.09 ?; 0.14a 1.75 + o.ogc 
Diabetic (6) 0.11 * 0.02a 443 + 74b 3.91 + 0.25a 1.08 * 0.12c 2.84 f 0.1 3a 
a p < 0.005 compared to control; b p < 0.025 compared to control; ’ not statistically different from control 0, > 0.05) 
The synthase was characterized in terms of its activity ratio in the absence and presence of G-6-P; apparent K, for G-6-P; alkali- 
labile phosphate content; and distribution of the phosphate between the trypsin-sensitive (TS) and trypsin-insensitive (TI) regions. 
Numbers in parenthesis indicate the number of synthase preparations in each group. Each synthase preparation contained hindleg 
muscle from 2 rabbits 
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hindlimb. Synthase from diabetic rabbits also has a 
depressed activity ratio, elevated K, for G-6-P, and an 
increased phosphate content to 3.9 mol/mol subunit 
(table 2). 
The distribution of the phosphate between the 
trypsin-sensitive (TS) and trypsin-insensitive (TI) 
regions is very interesting. The CAMP-dependent pro- 
tein kinase has a relative preference for phosphoryla- 
tion of the TS region whereas the Ca2’-dependent 
and CAMP-independent kinases phosphorylate pre- 
dominantly the TI region [1,4,17]. The distribution 
of phosphate in synthase from control rabbits was 1.4 
mol TI to 1 .O mol TS suggesting that synthase kinases 
other than the cAMP-dependent kinase are most active 
in the basal state. We have estimated in muscle extracts 
that under basal conditions of low CAMP and Ca’+ 
concentrations the CAMP-independent kinase(s) con- 
stitutes the major synthase kinase activity (see fig.3 
of [ 11). With epinephrine treatment the TI phosphate 
did not increase significantly (1.75 mol) but TS phos- 
phate doubled to 2.1 mol. This is entirely consistent 
with the known specificity of the CAMP-dependent 
kinase for the TS region [4], and the known activa- 
tion of this kinase by epinephrine in perfused rat 
muscle [18]. In response to diabetes the phosphate 
content of the TS region remained about the same as 
control (1 .l vs 1 .O) but TI phosphate doubled to 2.8. 
Thus, in the control rabbit insulin acts to decrease 
phosphorylation of the TI region. This conclusion is 
supported by preliminary results which show that 
insulin treatment of normal rabbits does specifically 
decrease the TX phosphate but not the TS phosphate. 
This effect of insulin could be through stin~ulation of 
a phosphatase which is specific for the TI region. We 
have reported that a highMr phosphatase from skeletal 
muscle preferentially dephosphorylates the TI region 
[18,19]. Alternatively, insulin could be inhibiting a 
protein kinase which preferentially phosphorylates 
the TI region. Our data are not consistent, however, 
with a mechanism in which insulin generates a factor 
which is inhibitory to the CAMP-dependent kinase 
[21,22]. Further studies on the effects of insulin on 
this system are in progress. 
Acknowledgements 
The authors wish to express their appreciation for 
the excellent technical assistance by MS Martha Bass. 
This work has been supported by the National Insti- 
tutes of Health grants AM 17808 and AM 26334. 
References 
[I] Soderling, T. R. (1979) Mol. Cell. Endocrind. 16, 
1577179. 
[2] Roach, P. J. and Larner, J. (1977) Mol. Cell. Biochem. 
IS, 179-200. 
[3] Nimmo, H. G. and Cohen, P. (1977) Adv. Cycl. Nucl. 
Res. 8, 145 -266. 
[4] Soderling, T. R., Jett, M. F., Hutson, N. J. and Khatra, 
B. S. (1977) J. Biol. Chem. 252,7517-7523. 
[S] Soderling, T. R., Sheorain, V. S. and Ericsson, L. H. 
(1979) FEBS Lett. 106, 181-184. 
[6] Roach, P. J., Rose&Perez, M. and Larner, J. (1977) 
FEBS Lett. 80,95-98. 
[?I Soderling, T. R., Hickenbottom, J. P., Reimann, E. M., 
Hunkeler, F. L., Walsh, D. A. and Krebs, E. G. (1970) 
J. Biol. Chem. 245,6317-6328. 
[S] Thomas, J. A., Schlender, K. K. and Lamer, J. (1968) 
Anal. Biochem. 25,486-499. 
[9] Stull, J. T. and Buss, J. E. (1977) J. Biol. Chem. 252, 
851-857. 
[IO] SoderIing,T. R. (1976) J. BioLChem. 251,4359-4364, 
[ 1 1 ] Roach, P. J., Takeda, I’. and Lamer, J. (1976) J. Biol. 
Chem. 251,1913-1919. 
[ 121 Kaslow, H. R., Eichner, R. D. and Mayer, S. E. (1979) 
J. Biol. Chem. 2.54,4674-4677. 
[ 131 Guinovart , J. J., Salavert, A., ,Massague, J., Ciudad, C. J., 
Salsas, E. and Itarte, E. (1979) FEBS Lett. 106, 
284-288. 
[ 14 f Kochan, R., Lamb, D. R., Reimann, E. M. and Schlender, 
K. K. (1981) Am. J. Physiol. in press. 
[IS] Danforth, W. H., Helmreich, E. and Coxi, C. F. (1962) 
Proc. Natl. Acad. Sci. 48, 1191-1199. 
[ 161 Chiasson, J. L., Aylward, J. H., Shikama, H. and Exton, 
J. H. (1981) FEBS Lett. 127.97-100. 
[17] Payne, M. E. and Soderling, T. R. (1980) J. Biol. Chem. 
255,8054-8056. 
[18] Dietz, M. R., Chiasson, J. L., Soderling, T. R. and 
Exton, J. H. (1980) J. Biol. Chem. 2.55, 2301-2307. 
[19] Hutson, N. J., Khatra, B. S. and Soderling, T. R. (1978) 
J. Biol. Chem. 253,2450-2545. 
[ZO] Khatra, B. S. and Soderling, T. R. (1978) J. Biol. Chem. 
253,5247-5250. 
]2l] Lamer, J., Galasko, G., Cheng, K., DePaoIi-Roach, 
A. A., Huang, L., Dnggy, P. and Kellog, J. (1979) 
Science 206, 1408-1410. 
[22] Walkenbach, R. J., Hazeo, R. and Larner, J. (1980) 
Biochim. Biophys. Acta 629,421-430. 
96 
